M. scrofulaceum belong to a non tuberculous mycobacterial group. It grows slow and widespread in the environment and is less common than other NTMs, but present globally. Reported cases come from worldwide locations. In the United States, it makes up 4% of NTM isolates, with higher prevalence noted in the South Atlantic region.
A 15 year retrospective chart review identified 17 patients with positive M. scrofulaceum cultures at a medical center. Among them, 10 were clinically diagnosed with infections demonstrating diverse diseases. Pulmonary and pleural infections occurred in four cases. Bone and joint infections associated with foreign bodies were also observed.
Adult pulmonary disease is correlated with structural lung issues. Extrapulmonary disease was common in immune suppressed individuals or with foreign body associated infections. A study at the National Global Health Centre, Keio University Hospital, and Medicine Center Hospital revealed eight pulmonary M. scrofulaceum disease cases. These affected middle-aged and older men with pulmonary diseases.
Literature frequently reported individuals with underlying silicosis or dust inhalation history. Treatment approaches varied; three of eight cases at the institutions and most from the literature review got the combination therapies.
Mycobacterium scrofulaceum belongs to the Mycobacteriaceae family. Thin rods typify its shape. Rod shapes are straight or curved when you look through a microscope.
These thin rods go up to 10 ÎĽm long, with most 5 ÎĽm long. Their width runs from 0.2 ÎĽm size based on growth surroundings and culture maturity. Forms range from rounded rods to extended rods.
One of unique feature sets M. scrofulaceum apart. When exposed to light, it reflects as yellow or orange pigment, it is classified as a photochromogen.
Lipids exposed on the surface of M. scrofulaceum’s outer membrane are crucial for virulence. The lipids interact and evade the immune responses, contributes to its pathogenicity. Esx family proteins, secreted by type VII secretion systems, influence virulence and host-pathogen interactions.
Like other non tuberculous mycobacteria in the M.avium complex, M. scrofulaceum has a large genome, complex gene organization, ability for horizontal gene transfer, and variable antigenic profile. It has lacosamide, macrolide, streptogramin resistance genes, making it resistant to so many antibiotics. The type strain L2238 (ATCC BAA837 and DSM 44803) was isolated from a cervical lymph node, helping understand its pathogenicity.
M. scrofulaceum’s pathogenicity stems from its genetic makeup, including a large genome, complex genes, and horizontal gene transfer capability, similar to other mycobacteria in the avium complex. Its MLSB resistance genes enhance antibiotic resistance. The cervical lymph node isolates L2238 serves as a reference for studying M. scrofulaceum’s genetics.
M. scrofulaceum is a slowly developing microbe. It’s part of the MAC group (Mycobacteriumavium complex). This pathogen exists in nature globally, creating health risks for humans. People with weak immunity face greater danger.
The transmission happens through breathing contaminated air or consuming polluted water and soil. Infected animals, especially birds, act as reservoirs. Person-to-person spread occurs, notably in healthcare facilities. Inhaling droplets containing the bacteria is a crucial transmission route.Â
Alveolar microbes take in the macrophages after they’re breathed in. This triggers an immune reÂsponse and granuloma formation in the area, with some tissue death. M. scrofulaceum being found in tonsils suggests that the throat’s lymphoid tissue is where it enters.Â
Direct bacterial entry can happen through puncture wounds on the skin, swelling the nearby lymph nodes. This invasion path shows that M. scrofulaceum has diffeÂrent ways of causing disease.Â
Lab tests need samples with lymph node fluid, coughed mucus, or tissue from affected areas. The right samples detect the M. scrofulaceum infections.
scrofulaceum is identified by culturing clinical samples. This slow-growing microbe takes 6 weeks to grow visible colonies on suitable media. Under a microscope, its acid-fast bacilli appear longer & thicker than M. tuberculosis, recognizes it. Based just on the smear appearance, it’s hard to distinguish from other non-tuberculous mycobacteria.
Molecular tests with DNA probes or 16s ribosomal sequencing accurately identify M. scrofulaceum. These techniques distinguish it from other NTM species. Newly described bacteria like M. parascrofulaceum account for some clinical isolates, challenges in differentiating it from M. scrofulaceum in the lab.
Lymph nodes in the neck often swell with M. scrofulaceum infection. This is the main symptom, especially in children and teens.
M. scrofulaceum also causes lung problems, skin infections, wide spread disease and bone issues. But neck swelling is the common sign.
Lab tests need samples with lymph node fluid, coughed mucus, or tissue from affected areas. The right samples detect the M. scrofulaceum infections.
 M. scrofulaceum is identified by culturing clinical samples. This slow-growing microbe takes 6 weeks to grow visible colonies on suitable media. Under a microscope, its acid-fast bacilli appear longer & thicker than M. tuberculosis, recognizes it. Based just on the smear appearance, it’s hard to distinguish from other non-tuberculous mycobacteria.
Molecular tests with DNA probes or 16s ribosomal sequencing accurately identify M. scrofulaceum. These techniques distinguish it from other NTM species. Newly described bacteria like M. parascrofulaceum account for some clinical isolates, challenges in differentiating it from M. scrofulaceum in the lab.
Avoid stagnant water as it is one of a source of scrofulaceum. Being careful in such areas lowers the contact with the bacteria.
One must be cautious around soil and dust, where scrofulaceum may exist.
Wash hands frequently, especially after outdoor activities or handling soil. It reduces Mycobacterium scrofulaceum
Use good water filters for drinking water. Clean water containers often to cut scrofulaceum exposure from water.
M. scrofulaceum belong to a non tuberculous mycobacterial group. It grows slow and widespread in the environment and is less common than other NTMs, but present globally. Reported cases come from worldwide locations. In the United States, it makes up 4% of NTM isolates, with higher prevalence noted in the South Atlantic region.
A 15 year retrospective chart review identified 17 patients with positive M. scrofulaceum cultures at a medical center. Among them, 10 were clinically diagnosed with infections demonstrating diverse diseases. Pulmonary and pleural infections occurred in four cases. Bone and joint infections associated with foreign bodies were also observed.
Adult pulmonary disease is correlated with structural lung issues. Extrapulmonary disease was common in immune suppressed individuals or with foreign body associated infections. A study at the National Global Health Centre, Keio University Hospital, and Medicine Center Hospital revealed eight pulmonary M. scrofulaceum disease cases. These affected middle-aged and older men with pulmonary diseases.
Literature frequently reported individuals with underlying silicosis or dust inhalation history. Treatment approaches varied; three of eight cases at the institutions and most from the literature review got the combination therapies.
Mycobacterium scrofulaceum belongs to the Mycobacteriaceae family. Thin rods typify its shape. Rod shapes are straight or curved when you look through a microscope.
These thin rods go up to 10 ÎĽm long, with most 5 ÎĽm long. Their width runs from 0.2 ÎĽm size based on growth surroundings and culture maturity. Forms range from rounded rods to extended rods.
One of unique feature sets M. scrofulaceum apart. When exposed to light, it reflects as yellow or orange pigment, it is classified as a photochromogen.
Lipids exposed on the surface of M. scrofulaceum’s outer membrane are crucial for virulence. The lipids interact and evade the immune responses, contributes to its pathogenicity. Esx family proteins, secreted by type VII secretion systems, influence virulence and host-pathogen interactions.
Like other non tuberculous mycobacteria in the M.avium complex, M. scrofulaceum has a large genome, complex gene organization, ability for horizontal gene transfer, and variable antigenic profile. It has lacosamide, macrolide, streptogramin resistance genes, making it resistant to so many antibiotics. The type strain L2238 (ATCC BAA837 and DSM 44803) was isolated from a cervical lymph node, helping understand its pathogenicity.
M. scrofulaceum’s pathogenicity stems from its genetic makeup, including a large genome, complex genes, and horizontal gene transfer capability, similar to other mycobacteria in the avium complex. Its MLSB resistance genes enhance antibiotic resistance. The cervical lymph node isolates L2238 serves as a reference for studying M. scrofulaceum’s genetics.
M. scrofulaceum is a slowly developing microbe. It’s part of the MAC group (Mycobacteriumavium complex). This pathogen exists in nature globally, creating health risks for humans. People with weak immunity face greater danger.
The transmission happens through breathing contaminated air or consuming polluted water and soil. Infected animals, especially birds, act as reservoirs. Person-to-person spread occurs, notably in healthcare facilities. Inhaling droplets containing the bacteria is a crucial transmission route.Â
Alveolar microbes take in the macrophages after they’re breathed in. This triggers an immune reÂsponse and granuloma formation in the area, with some tissue death. M. scrofulaceum being found in tonsils suggests that the throat’s lymphoid tissue is where it enters.Â
Direct bacterial entry can happen through puncture wounds on the skin, swelling the nearby lymph nodes. This invasion path shows that M. scrofulaceum has diffeÂrent ways of causing disease.Â
Lab tests need samples with lymph node fluid, coughed mucus, or tissue from affected areas. The right samples detect the M. scrofulaceum infections.
scrofulaceum is identified by culturing clinical samples. This slow-growing microbe takes 6 weeks to grow visible colonies on suitable media. Under a microscope, its acid-fast bacilli appear longer & thicker than M. tuberculosis, recognizes it. Based just on the smear appearance, it’s hard to distinguish from other non-tuberculous mycobacteria.
Molecular tests with DNA probes or 16s ribosomal sequencing accurately identify M. scrofulaceum. These techniques distinguish it from other NTM species. Newly described bacteria like M. parascrofulaceum account for some clinical isolates, challenges in differentiating it from M. scrofulaceum in the lab.
Lymph nodes in the neck often swell with M. scrofulaceum infection. This is the main symptom, especially in children and teens.
M. scrofulaceum also causes lung problems, skin infections, wide spread disease and bone issues. But neck swelling is the common sign.
Lab tests need samples with lymph node fluid, coughed mucus, or tissue from affected areas. The right samples detect the M. scrofulaceum infections.
 M. scrofulaceum is identified by culturing clinical samples. This slow-growing microbe takes 6 weeks to grow visible colonies on suitable media. Under a microscope, its acid-fast bacilli appear longer & thicker than M. tuberculosis, recognizes it. Based just on the smear appearance, it’s hard to distinguish from other non-tuberculous mycobacteria.
Molecular tests with DNA probes or 16s ribosomal sequencing accurately identify M. scrofulaceum. These techniques distinguish it from other NTM species. Newly described bacteria like M. parascrofulaceum account for some clinical isolates, challenges in differentiating it from M. scrofulaceum in the lab.
Avoid stagnant water as it is one of a source of scrofulaceum. Being careful in such areas lowers the contact with the bacteria.
One must be cautious around soil and dust, where scrofulaceum may exist.
Wash hands frequently, especially after outdoor activities or handling soil. It reduces Mycobacterium scrofulaceum
Use good water filters for drinking water. Clean water containers often to cut scrofulaceum exposure from water.
M. scrofulaceum belong to a non tuberculous mycobacterial group. It grows slow and widespread in the environment and is less common than other NTMs, but present globally. Reported cases come from worldwide locations. In the United States, it makes up 4% of NTM isolates, with higher prevalence noted in the South Atlantic region.
A 15 year retrospective chart review identified 17 patients with positive M. scrofulaceum cultures at a medical center. Among them, 10 were clinically diagnosed with infections demonstrating diverse diseases. Pulmonary and pleural infections occurred in four cases. Bone and joint infections associated with foreign bodies were also observed.
Adult pulmonary disease is correlated with structural lung issues. Extrapulmonary disease was common in immune suppressed individuals or with foreign body associated infections. A study at the National Global Health Centre, Keio University Hospital, and Medicine Center Hospital revealed eight pulmonary M. scrofulaceum disease cases. These affected middle-aged and older men with pulmonary diseases.
Literature frequently reported individuals with underlying silicosis or dust inhalation history. Treatment approaches varied; three of eight cases at the institutions and most from the literature review got the combination therapies.
Mycobacterium scrofulaceum belongs to the Mycobacteriaceae family. Thin rods typify its shape. Rod shapes are straight or curved when you look through a microscope.
These thin rods go up to 10 ÎĽm long, with most 5 ÎĽm long. Their width runs from 0.2 ÎĽm size based on growth surroundings and culture maturity. Forms range from rounded rods to extended rods.
One of unique feature sets M. scrofulaceum apart. When exposed to light, it reflects as yellow or orange pigment, it is classified as a photochromogen.
Lipids exposed on the surface of M. scrofulaceum’s outer membrane are crucial for virulence. The lipids interact and evade the immune responses, contributes to its pathogenicity. Esx family proteins, secreted by type VII secretion systems, influence virulence and host-pathogen interactions.
Like other non tuberculous mycobacteria in the M.avium complex, M. scrofulaceum has a large genome, complex gene organization, ability for horizontal gene transfer, and variable antigenic profile. It has lacosamide, macrolide, streptogramin resistance genes, making it resistant to so many antibiotics. The type strain L2238 (ATCC BAA837 and DSM 44803) was isolated from a cervical lymph node, helping understand its pathogenicity.
M. scrofulaceum’s pathogenicity stems from its genetic makeup, including a large genome, complex genes, and horizontal gene transfer capability, similar to other mycobacteria in the avium complex. Its MLSB resistance genes enhance antibiotic resistance. The cervical lymph node isolates L2238 serves as a reference for studying M. scrofulaceum’s genetics.
M. scrofulaceum is a slowly developing microbe. It’s part of the MAC group (Mycobacteriumavium complex). This pathogen exists in nature globally, creating health risks for humans. People with weak immunity face greater danger.
The transmission happens through breathing contaminated air or consuming polluted water and soil. Infected animals, especially birds, act as reservoirs. Person-to-person spread occurs, notably in healthcare facilities. Inhaling droplets containing the bacteria is a crucial transmission route.Â
Alveolar microbes take in the macrophages after they’re breathed in. This triggers an immune reÂsponse and granuloma formation in the area, with some tissue death. M. scrofulaceum being found in tonsils suggests that the throat’s lymphoid tissue is where it enters.Â
Direct bacterial entry can happen through puncture wounds on the skin, swelling the nearby lymph nodes. This invasion path shows that M. scrofulaceum has diffeÂrent ways of causing disease.Â
Lab tests need samples with lymph node fluid, coughed mucus, or tissue from affected areas. The right samples detect the M. scrofulaceum infections.
scrofulaceum is identified by culturing clinical samples. This slow-growing microbe takes 6 weeks to grow visible colonies on suitable media. Under a microscope, its acid-fast bacilli appear longer & thicker than M. tuberculosis, recognizes it. Based just on the smear appearance, it’s hard to distinguish from other non-tuberculous mycobacteria.
Molecular tests with DNA probes or 16s ribosomal sequencing accurately identify M. scrofulaceum. These techniques distinguish it from other NTM species. Newly described bacteria like M. parascrofulaceum account for some clinical isolates, challenges in differentiating it from M. scrofulaceum in the lab.
Lymph nodes in the neck often swell with M. scrofulaceum infection. This is the main symptom, especially in children and teens.
M. scrofulaceum also causes lung problems, skin infections, wide spread disease and bone issues. But neck swelling is the common sign.
Lab tests need samples with lymph node fluid, coughed mucus, or tissue from affected areas. The right samples detect the M. scrofulaceum infections.
 M. scrofulaceum is identified by culturing clinical samples. This slow-growing microbe takes 6 weeks to grow visible colonies on suitable media. Under a microscope, its acid-fast bacilli appear longer & thicker than M. tuberculosis, recognizes it. Based just on the smear appearance, it’s hard to distinguish from other non-tuberculous mycobacteria.
Molecular tests with DNA probes or 16s ribosomal sequencing accurately identify M. scrofulaceum. These techniques distinguish it from other NTM species. Newly described bacteria like M. parascrofulaceum account for some clinical isolates, challenges in differentiating it from M. scrofulaceum in the lab.
Avoid stagnant water as it is one of a source of scrofulaceum. Being careful in such areas lowers the contact with the bacteria.
One must be cautious around soil and dust, where scrofulaceum may exist.
Wash hands frequently, especially after outdoor activities or handling soil. It reduces Mycobacterium scrofulaceum
Use good water filters for drinking water. Clean water containers often to cut scrofulaceum exposure from water.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
